Suppr超能文献

为印度精神分裂症患者开发个性化戒烟干预方案(PTCIP)。

Development of a Personalized Tobacco Cessation Intervention Package (PTCIP) for Persons with Schizophrenia in India.

作者信息

Rajalu Banu Manickam, Jayarajan Deepak, Muliyala Krishna Prasad, Sharma Priyamvada, Gandhi Sailaxmi, Chand Prabhat Kumar

机构信息

Dept. of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.

Dept. of Clinical Pharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.

出版信息

Indian J Psychol Med. 2023 Mar;45(2):132-138. doi: 10.1177/02537176221105581. Epub 2022 Jul 15.

Abstract

BACKGROUND

Among persons with schizophrenia (PwS), tobacco use is higher in comparison to the general population, contributing to greater morbidity and mortality. Pharmacological interventions combined with psychosocial interventions are effective in tobacco cessation. While the effectiveness of extant psychosocial interventions-when used in isolation-seems limited, developing better combinations of interventions could help treatment providers deliver tobacco cessation services to PwS at different stages of motivation to quit. We aimed to develop a personalized tobacco cessation intervention package (PTCIP) for PwS.

METHODS

The stage-based intervention package was developed through a systematic review of interventions for tobacco cessation, the authors' clinical experience, and expert validation. The components of the intervention package, developed for PwS visiting the outpatient psychiatric department, were retained, removed, or added based on the content validity ratio (CVR).

RESULTS

The final components included brief advice, principles of motivational interviewing, psychoeducation, decisional balance matrix, positive reinforcement, offering various treatment options, personalized feedback using a smoking-risk calculator, and prediction of cardiovascular risk using the WHO package of essential noncommunicable disease (PEN). The delivery of the intervention package was refined based on pilot testing in eight participants.

CONCLUSION

The tailored package was designed to be delivered by a mental health professional as a single comprehensive 40 min to 45 min face-to-face session, integrated with routine follow-up visits, followed by two telephonic conversations in the second and third week of the initial session. The package needs to be tested in a randomized controlled trial for its effectiveness.

摘要

背景

在精神分裂症患者中,吸烟率高于普通人群,导致更高的发病率和死亡率。药物干预与心理社会干预相结合对戒烟有效。虽然现有的心理社会干预单独使用时效果似乎有限,但开发更好的干预组合可以帮助治疗提供者在精神分裂症患者戒烟动机的不同阶段提供戒烟服务。我们旨在为精神分裂症患者开发一个个性化的戒烟干预方案(PTCIP)。

方法

基于对戒烟干预措施的系统评价、作者的临床经验和专家验证,开发了基于阶段的干预方案。根据内容效度比(CVR),对为到门诊精神科就诊的精神分裂症患者开发的干预方案的组成部分进行保留、删除或添加。

结果

最终的组成部分包括简短建议、动机性访谈原则、心理教育、决策平衡矩阵、积极强化、提供多种治疗选择、使用吸烟风险计算器进行个性化反馈以及使用世界卫生组织基本非传染性疾病一揽子方案(PEN)预测心血管风险。基于对8名参与者的试点测试,对干预方案进行了优化。

结论

量身定制的方案设计为由心理健康专业人员以40至45分钟的单一综合面对面会议形式提供,并与常规随访相结合,随后在初次会议的第二周和第三周进行两次电话交谈。该方案的有效性需要在随机对照试验中进行测试。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0da/10011849/59d86043f4a4/10.1177_02537176221105581-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验